SEB SA/ FR0000121709 /
9/6/2024 4:54:36 PM | Chg. -1.85 | Volume | Bid7/19/2024 | Ask7/19/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
90.80EUR | -2.00% | 139 Turnover: 12,629.20 |
-Bid Size: - | -Ask Size: - | 5.01 bill.EUR | 2.89% | 12.92 |
GlobeNewswire
7/17
SocialFi Platform RECRD Emerges From Stealth With $4M Funding Led by Sui Foundation & Alphabit Fund;...
GlobeNewswire
6/25
PEAK:AIO Commits to the Future of AI Healthcare; Announces the Appointment of Professor Sebastien Ou...
GlobeNewswire
1/29
Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for...
GlobeNewswire
1/22
ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the...
GlobeNewswire
9/25/2023
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Livi...
Newsfile Corp
10/10/2022
GaiaLens Unveils its ESG Reporting Capability as Part of its Data-Driven, AI-Based ESG Analytics Pla...
GlobeNewswire
1/27/2022
F2 Strategy’s 2022 Outlook Report Shows Cryptocurrency Adoption, Data Aggregation and Operations Aut...
GlobeNewswire
12/22/2021
MicroEJ and Groupe SEB, leader in small domestic appliances, announce their collaboration in the dev...
GlobeNewswire
11/3/2021
Bestselling 'Beauty of Horror' Creator Alan Robert Launches Whitelist for 'Monster Chompers' NFT Col...
GlobeNewswire
9/16/2021
F2 Strategy Trailblazes WealthTech Space with Record Growth of Outsourced CTO and Consulting Service...
GlobeNewswire
7/12/2021
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-...
GlobeNewswire
5/25/2021
Sinch AB (publ): Sinch completes a directed new share issue of 7,232,077 shares, raising approximate...
GlobeNewswire
5/24/2021
Sinch AB (publ): Sinch evaluates the conditions to carry out a directed new share issue